Fotios Panitsas

12PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematologyInorganic materials (incl. nanomaterials)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 14, 2026
Focus on Extremely Late Relapses in Hodgkin Lymphoma: A Single Center Analysis.

Athanasios Liaskas, Fotios Panitsas, Maria K Angelopoulou

|Oct 16, 2025
Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.

Maria Dimou, Rodanthi Fioretzaki, Calliope Zerzi

|Jan 23, 2024
Prognostic Impact of Serum β<sub>2</sub>-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients.

Theodoros P Vassilakopoulos, Maria Arapaki, Panagiotis T Diamantopoulos

|Nov 14, 2023
Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.

Alex Rampotas, Luke Carter-Brzezinski, Tim C P Somervaille

|Jan 31, 2023
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients.

Faouzi Djebbari, Alexandros Rampotas, Grant Vallance

|Oct 31, 2022
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.

Theodoros P Vassilakopoulos, Fotios Panitsas, Zois Mellios

Pageof 2

Frequent Collaborators

5 joint publications

Theodoros P Vassilakopoulos

5 joint publications

Maria Dimou

3 joint publications

Marina Siakantaris

3 joint publications

Faouzi Djebbari